Transplantation Conditioning
"Transplantation Conditioning" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Preparative treatment of transplant recipient with various conditioning regimens including radiation, immune sera, chemotherapy, and/or immunosuppressive agents, prior to transplantation. Transplantation conditioning is very common before bone marrow transplantation.
Descriptor ID |
D019172
|
MeSH Number(s) |
E02.095.465.425.450.800 E05.478.610.800
|
Concept/Terms |
Transplantation Conditioning- Transplantation Conditioning
- Conditioning, Transplantation
- Conditionings, Transplantation
- Transplantation Conditionings
|
Below are MeSH descriptors whose meaning is more general than "Transplantation Conditioning".
Below are MeSH descriptors whose meaning is more specific than "Transplantation Conditioning".
This graph shows the total number of publications written about "Transplantation Conditioning" by people in this website by year, and whether "Transplantation Conditioning" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
Year | Major Topic | Minor Topic | Total |
---|
1996 | 0 | 1 | 1 |
1997 | 2 | 2 | 4 |
1998 | 1 | 1 | 2 |
1999 | 2 | 1 | 3 |
2000 | 1 | 4 | 5 |
2001 | 3 | 2 | 5 |
2002 | 2 | 3 | 5 |
2003 | 3 | 4 | 7 |
2004 | 4 | 6 | 10 |
2005 | 4 | 1 | 5 |
2006 | 4 | 4 | 8 |
2007 | 1 | 1 | 2 |
2008 | 4 | 0 | 4 |
2009 | 7 | 5 | 12 |
2010 | 3 | 9 | 12 |
2011 | 7 | 6 | 13 |
2012 | 2 | 3 | 5 |
2013 | 11 | 5 | 16 |
2014 | 6 | 1 | 7 |
2015 | 12 | 1 | 13 |
2016 | 3 | 4 | 7 |
2017 | 6 | 2 | 8 |
2018 | 1 | 2 | 3 |
2019 | 4 | 3 | 7 |
2020 | 1 | 10 | 11 |
2021 | 1 | 4 | 5 |
2022 | 0 | 1 | 1 |
2023 | 0 | 2 | 2 |
To return to the timeline,
click here.
Below are the most recent publications written about "Transplantation Conditioning" by people in Profiles.
-
Haploidentical allogeneic stem cell transplantation with post-transplant cyclophosphamide and subsequent kidney transplant for patients with severe sickle cell disease with end-stage kidney disease (ESKD). Bone Marrow Transplant. 2023 Jul; 58(7):835-838.
-
Survival of TP53-mutated acute myeloid leukemia patients receiving allogeneic stem cell transplantation after first induction or salvage therapy: results from the Consortium on Myeloid Malignancies and Neoplastic Diseases (COMMAND). Leukemia. 2023 04; 37(4):799-806.
-
CD34+ -selected hematopoietic stem cell transplant conditioned with a myeloablative regimen in patients with advanced myelofibrosis. Bone Marrow Transplant. 2022 07; 57(7):1101-1107.
-
Allogeneic transplant graft source - conditioning - GVHD prophylaxis: don't mix and match! Leuk Lymphoma. 2022 01; 63(1):7-9.
-
Outcomes of pediatric patients with therapy-related myeloid neoplasms. Bone Marrow Transplant. 2021 12; 56(12):2997-3007.
-
Outcomes and Utilization Trends of Front-Line Autologous Hematopoietic Cell Transplantation for Mantle Cell Lymphoma. Transplant Cell Ther. 2021 11; 27(11):911.e1-911.e7.
-
Hypoxia Preconditioning Promotes the Proliferation and Migration of Human Urine-Derived Stem Cells in Chronically Injured Liver of Mice by Upregulating CXCR4. Stem Cells Dev. 2021 05 15; 30(10):526-536.
-
Superior survival with pediatric-style chemotherapy compared to myeloablative allogeneic hematopoietic cell transplantation in older adolescents and young adults with Ph-negative acute lymphoblastic leukemia in first complete remission: analysis from CALGB 10403 and the CIBMTR. Leukemia. 2021 07; 35(7):2076-2085.
-
Allogeneic Transplant Conditioning Regimens for Patients With Non-Hodgkin Lymphoma. JAMA Oncol. 2020 12 01; 6(12):1983-1984.
-
Prostate Cancer Outcomes Following Solid-Organ Transplantation: A SEER-Medicare Analysis. J Natl Cancer Inst. 2020 08 01; 112(8):847-854.